glp-1 drug made by eli lilly stock soars on encouraging results for daily weight-loss pill Eli Lilly is spending billions

Inflammation usually resolves spontaneously and is essential for the repair process

Quitting at week 4 because the scale has not moved is like planting a seed and digging it up after three days to check for roots

What are the goals of treatment

Tirzepatide remained available for patients with type 2 diabetes under its anti-diabetic (ADM) formulation (sold as Mounjaro)

Patients with prediabetes, obesity, or metabolic syndrome could potentially receive treatment sooner, particularly if clinical evidence continues to support cardiovascular and renal benefits

As expected, glucagon infusion caused an increase in glucose which was largely neutralised by co-infusion with GLP-1